Foravirumab is a monoclonal antibody for the prophylaxis of rabies.[1] It is under development by Sanofi/Crucell.[2]

Foravirumab
Monoclonal antibody
TypeWhole antibody
SourceHuman
Targetrabies virus glycoprotein
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
ChEMBL
Chemical and physical data
FormulaC6400H9914N1718O1998S44
Molar mass144304.38 g·mol−1
 ☒NcheckY (what is this?)  (verify)

References

edit
  1. ^ International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.
  2. ^ Khardori NM (2011). Biologic Response Modifiers in Infectious Diseases, An Issue of Infectious Disease Clinics. London: Elsevier Health Sciences. p. 158. ISBN 978-1-4557-1207-6.